FluMist Disease Interactions
There are 4 disease interactions with FluMist (influenza virus vaccine, live).
Influenza vaccine (applies to FluMist) GBS
Major Potential Hazard, Moderate plausibility. Applicable conditions: Guillain-Barre Syndrome
The use of influenza vaccine has been associated with an elevated risk of Guillain-Barré syndrome (GBS). It is not recommended to administer this vaccine if GBS has occurred within 6 weeks following previous influenza vaccination. Care and close monitoring is recommended and consideration of the potential benefits and risks should be assessed.
References
- "Product Information. Fluzone (influenza virus vaccine, inactivated)." Connaught Laboratories Inc
- (2015) "Product Information. Fluzone Intradermal 2014-2015 (influenza virus vaccine, inactivated)." sanofi pasteur
Influenza vaccine (applies to FluMist) neurologic disorders
Major Potential Hazard, Moderate plausibility.
Influenza vaccine should be withheld, pending stabilization, in patients with active neurologic disorders associated with changing neurological status. Neurologic signs or symptoms following administration of an influenza vaccine is a contraindication to future use.
References
- "Product Information. Fluzone (influenza virus vaccine, inactivated)." Connaught Laboratories Inc
Vaccination (applies to FluMist) infections
Major Potential Hazard, High plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral, Fever
Ideally, vaccination should occur when an individual is healthy, thus minimizing the risk of an adverse host reaction and/or vaccine failure. However, a current or recent infection does not necessarily preclude the use of vaccines, depending on the severity of the patient's symptoms and their etiology. Superficial infections and minor acute illnesses such as a mild upper respiratory infection with or without low-grade fever do not contraindicate immunization, particularly if prompt administration of a vaccine is deemed necessary or beneficial. In fact, when vaccines are administered during the course of a minor illness, the risk of adverse events is not increased, and serum antibody response is not often diminished. On the other hand, if fever or symptoms suggest a moderate or severe illness, it is usually appropriate to withhold vaccination until the patient has recovered. In addition to the potential risks already mentioned, evolving signs and symptoms of the illness can sometimes confound the diagnosis of a vaccine reaction if it develops. In the presence of any infection, the decision to administer or withhold/defer immunization should take into consideration the benefits versus the risks to an individual patient.
References
- (2022) "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc
- (2022) "Product Information. Varivax (varicella virus vaccine)." Merck & Co., Inc
- (2022) "Product Information. Pneumovax 23 (pneumococcal 23-polyvalent vaccine)." Merck & Co., Inc
- (2022) "Product Information. Mumpsvax (mumps virus vaccine)." Merck & Co., Inc
- (2022) "Product Information. Meruvax II (rubella virus vaccine)." Merck & Co., Inc
- (2022) "Product Information. Attenuvax (measles virus vaccine)." Merck & Co., Inc
- (2022) "Product Information. Orimune (poliovirus vaccine, live, trivalent)." Lederle Laboratories
- (2001) "Product Information. YF-Vax (yellow fever vaccine)." sanofi pasteur
- "Product Information. Omnihib (haemophilus b conjugate vaccine (obsolete))." SmithKline Beecham
- "Product Information. Menomune A/C/Y/W-135 (meningococcal polysaccharide vaccine)." Connaught Laboratories Inc
- (2001) "Product Information. Plague Vaccine (plague vaccine)." Greer Laboratories Inc
- American Academy of Pediatrics. Committee on Infectious Diseases; Peter G, ed. (1997) "Red BooK: Report of the Committee on Infectious Diseases." Grove Village, IL: American Academy of Pediatrics
- "Product Information. Cholera Vaccine (cholera vaccine)." Wyeth-Ayerst Laboratories
- "Product Information. Havrix (HepA) (hepatitis A adult vaccine)." SmithKline Beecham
- (2022) "Product Information. Engerix-B (HepB) (hepatitis B adult vaccine)." Apothecon Inc
- (2006) "Product Information. Zostavax (zoster vaccine live)." Merck & Co., Inc
- (2006) "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc
- (2016) "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc
Intranasal influenza vaccine (applies to FluMist) asthma
Moderate Potential Hazard, Moderate plausibility.
Intranasal influenza vaccine has been associated with increased wheezing. Caution is recommended when using intranasal influenza vaccine in children with recurrent wheezing and asthmatic patients as these patients may be at an increased risk of developing wheezing.
References
- (2022) "Product Information. FluMist (influenza virus vaccine, live)." Medimmune Inc
FluMist drug interactions
There are 382 drug interactions with FluMist (influenza virus vaccine, live).
More about FluMist (influenza virus vaccine, live)
- FluMist consumer information
- Check interactions
- Compare alternatives
- Reviews (14)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.